Диссертация (1154715), страница 24
Текст из файла (страница 24)
Sheikh, A. There is no evidence of an inverse relationship between TH2-mediatedatopy and TH1-mediated autoimmune disorders: lack of support for the hygienehypothesis / A. Sheikh, L. Smeeth, R. Hubbard // J Allergy Clin Immunol. — 2003. —Vol. 111 (1). — P. 131-135.184. Shirakawa, T.
The inverse association between tuberculin responses and atopicdisorder / T. Shirakawa, T. Enomoto, S. Shimazu, J.M. Hopkin // Science — 1997. —Vol. 275 (5296). — P. 77-79.154185. Siegal, S. Atopy and diabetes mellitus / S. Siegal, J. Herzstein // J Allergy. —1954. — Vol. 25 (1). — P. 25-27.186. Siemiatycki, J. Case-control study of IDDM / J. Siemiatycki, E. Colle, S.Campbell, R.A. Dewar, M.M.
Belmonte // Diabetes Care. — 1989. — Vol. 12 (3). — P.209-216.187. Simpson, C.R. Coincidence of immune-mediated diseases driven by Th1 and Th2subsets suggests a common aetiology: a population-based study using computerizedGeneral Practice data / C.R. Simpson, W.J. Anderson, P.J. Helms, M.W. Taylor, L.Watson, G.J. Prescott, D.J. Godden, R.N. Barker // Clin Exp Allergy. — 2002. — Vol.32 (1). — P.
37-42.188. Slatore C.G. Association of Inhaled Corticosteroid Use with Serum GlucoseConcentration in a Large Cohort / C.G. Slatore, C.L. Bryson, D.H. Au // Am J Med —2009. — Vol. 122 (5). — P. 472-478.189. Smith, A.P. Mechanisms of abnormal glucose metabolism during the treatment ofacute severe asthma / A.P.
Smith, J. Banks, K. Buchanan, B. Cheong, K.A.Gunawardena // Q Journal Med. — 1992. — Vol. 82 (297). — P. 71-80.190. Sornasse, T. Differentiation and stability of T helper 1 and 2 cells derived fromnaïve human neonatal CD4+ T cells, analyzed at the single-cell level / T.
Sornasse, P.V.Larenas, K.A. Davis, J.E. de Vries, H. Yssel // J Exp Med. — 1996. — Vol. 184 (2). —P. 473-483.191. Stankov, K. Genetic and epigenetic factors in etiology of diabetes mellitus type 1/ K. Stankov, D. Benc, D. Draskovic // Pediatrics. — 2013. — Vol. 132 (6). — P. 11121122.192. Stene, L.C. Atopic eczema and the risk of childhood type 1 diabetes in VestAgder County, Norway / L.C. Stene, J. Ulriksen, G.
Joner // Eur J Endocrinol. —2000. — Vol. 142 (1). — P. 160.193. Stene, L.S. An inverse association between history of childhood eczema andsubsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ,PTPN22, or CTLA4 polymorphisms / L.C. Stene, K.S. Rønningen, M. Bjørnvold, D.E.Undlien, G.
Joner // Pediatr Diabetes. — 2010. — Vol. 11 (6). — P. 386-93.155194. Stene, L.C. Atopic disorders and risk of childhood-onset type 1 diabetes inindividuals / L.C. Stene, G. Joner // Clin Exp Allergy. — 2004. — Vol. 34 (2). — P.201-206.195. Stene, L.C. Relation between occurrence of type 1 diabetes and asthma / L.C.Stene, P. Nafstad // Lancet. — 2001. — Vol. 357 (9256). — P.
607-608.196. Strachan, D.P. Hay fever, hygiene, and household size / D.P. Strachan // BMJ. —1989. — Vol. 299 (6710). — P. 1259-1260.197. Strömberg, L.G. Atopic allergy and delayed hypersensitivity in children withdiabetes / L.G. Strömberg, G.J. Ludvigsson, B. Björkstén // J Allergy Clin Immunol. —1995. — Vol.
96 (2). — P. 188-192.198. Subbarao, P. Asthma: epidemiology, etiology and risk factors / P. Subbarao, P.J.Mandhane, M.R. Sears // CMAJ. — 2009. — Vol. 181(9). — P. 181-190.199. Swern, N. Incidence of diabetes mellitus in asthmatic patients / N. Swern // JAllergy. — 1931. — Vol. 2 (5). — P. 375-378.200. Tabares-Seisdedos R. Inverse comorbidity: the power of paradox in theadvancement of science / R. Tabares-Seisdedos, J.M.
Valderas // J. Comorbidity. —2013. — Vol. 3. — P. 1-3.201. Takeda, M. Allergic airway hyperresponsiveness, inflammation, and remodelingdo not develop in phosphoinositide 3-kinase gamma-deficient mice / M. Takeda, W. Ito,M. Tanabe, S. Ueki, H.
Kato, J. Kihara, T. Tanigai, T. Chiba, K. Yamaguchi, H.Kayaba, Y. Imai, K. Okuyama, I. Ohno, T. Sasaki, J. Chihara // J Allergy ClinImmunol. — 2009. — Vol. 123 (4). — P. 805-812.202. Taleb, N. Prevalence of asthmatic symptoms in Lebanese patients with type 1diabetes and their unaffected siblings compared to age-matched controls / N. Taleb, P.Bou Khalil, M.S.
Zantout, P. Zalloua, S.T. Azar // Acta Diabetol. — 2010. — Vol. 47(1). — P. 13-18.203. Taplin, C.E. Autoantibodies in type 1 diabetes / C.E. Taplin, J.M. Barker //Autoimmunity. — 2008. — Vol. 41 (1). — P. 11-18.156204. Thavagnanam, S. A meta-analysis of the association between Caesarean sectionand childhood asthma / S.Thavagnanam, J. Fleming, A. Bromley, M.D. Shields, C.R.Cardwell // Clin Exp Allergy. — 2008. — Vol. 38 (4). — P. 629-633.205.
The global asthma report 2014 [Электронный ресурс]. — Auckland, NewZealand:GlobalAsthmaNetwork,2014.—Режимдоступа:http://www.globalasthmareport.org/about/gan.php.206. Thomsen, S.F. Relationship between type 1 diabetes and atopic diseases in a twinpopulation / S.F. Thomsen, D.L. Duffy, K.O. Kyvik, A. Skytthe, V. Backer //Allergy.— 2011. — Vol. 66 (5). — P. 645-647.207. Toivonen, A.
Soluble adhesion molecules in preclinical type 1 diabetes / A.Toivonen, P. Kulmala, K. Savola, H.K. Akerblom, M. Knip // Pediatr Res. — 2001. —Vol. 49 (1). — P. 24-29.208. Tosca, M.A. Discrepancy between sensitization to inhaled allergens andrespiratory symptoms in pediatric patients with type 1 diabetes mellitus / M.A. Tosca,E. Villa, M.
Silvestri, G. D'Annunzio, A. Pistorio, M. Aicardi, L. Minicucci, R. Lorini,G.A. Rossi // Pediatr Allergy Immunol. — 2009. — Vol. 20 (4). — P. 385-391.209. Tosca, M.A. May T1 diabetes mellitus protect from asthma? / M.A. Tosca, M.Silòvestri, G. D'Annunzio, R. Lorini, G.A. Rossi, G. Ciprandi // Allergol etimmunopathol (Madr.).
— 2013. — Vol. 41 (5). — P. 288-291.210. Tosca, M.A. T1 diabetes and allergic diseases in children: Correspondence to thepaper of Thomsen et al. / M.A. Tosca, G. Ciprandi, M. Silvestri, G. D'Annunzio, R.Lorini, G.A. Rossi // Allergy. — 2011. — Vol. 66 (12). — P. 1612-1613.211. Trembleau, S. IL-12 administration accelerates autoimmune diabetes in wild-typeand IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protectiveeffects of IL-12-induced IFN-gamma / S. Trembleau, G.
Penna, S. Gregori, N.Giarratana, L. Adorini // J. Immunol. — 2003. — Vol. 170 (11). — P. 5491-5501.212. Tzeng, S.T. Prevalence of atopy in children with type 1 diabetes mellitus incentral Taiwan / S.T. Tzeng, S.G. Hsu, L.S. Fu, C.S. Chi // J Microbiol Immunol Infect.— 2007. — Vol. 40 (1). — P. 74-78.157213. Van Gent, R. Lung function abnormalities in children with type1 diabetes / R.van Gent, H.J. Brackel, M. de Vroede, C.K. van der Ent // Respiratory medicine.
—2002. — Vol. 96 (12). — P. 976-978.214. Villa-Nova, H. Prevalence of allergic diseases and/or allergic sensitisation inchildren and adolescents with type 1 diabetes mellitus / H. Villa-Nova, A.M. SpinolaCastro, F.E. Garcia, D. Solé // Allergol Immunopathol (Madr). — 2015. — Vol. 43 (2).— P. 157-161.215. Von Mutius, E. Environmental factors influencing the development andprogression of pediatric asthma / E. von Mutius // J Allergy Clin Immunol. — 2002.
—Vol. 109 (6). — P. 525-532.216. Wahlberg, J. Asthma and allergic symptoms and type 1 diabetes-relatedautoantibodies in 2.5-yr-old children / J. Wahlberg, O. Vaarala, J. Ludvigsson // PediatrDiabetes. — 2011. — Vol. 12 (7). — P. 604-610.217. Wang, Y.H. The potential role of interleukin-17 in severe asthma / Y.H. Wang,M. Wills-Karp // Curr Allergy Asthma Rep. — 2011. — Vol.
11 (5). — P. 388-394.218. Wenzel, S. Dupilumab in persistent asthma with elevated eosinophil levels / S.Wenzel, L. Ford, D. Pearlman, S. Spector, et al. // N Engl J Med. — 2013. — Vol. 368(26). — P. 2455-2466.219. Whitehead, A. Meta-analysis of controlled clinical trials / Whitehead, A. —Chichester, England: John Wiley & Sons Inc, 2002. — 352 p.220. WHO child growth standards.
Length/height-for-age, weight-for-age, weight-forlength, weight-for-height and body mass index-for-age: methods and development[Электронный ресурс]. — Geneva, Switzerland: WHO, 2006. — Режим доступа:http://www.who.int/childgrowth/standards/Technical_report.pdf221. Wiethop, B.V. Glycemic actions of alanine and terbutaline in IDDM / B.V.Wiethop, P.E. Cryer // Diabetes Care.